These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28551632)

  • 1. The Prognostic Value of the Immunohistochemical Expression of Phosphorylated RB and p16 Proteins in Association with Cyclin D1 and the p53 Pathway in a Large Cohort of Patients with Breast Cancer Treated with Taxane-based Adjuvant Chemotherapy.
    Gavressea T; Kalogeras KT; Koliou GA; Zagouri F; Lazaridis G; Gogas H; Tsigaridas K; Koutras A; Petraki K; Markopoulos C; Pazarli E; Aravantinos G; Papadimitriou C; Papakostas P; Koufopoulos N; Karanikiotis C; Chrisafi S; Kalofonos HP; Pectasides D; Fountzilas G; Pavlakis K
    Anticancer Res; 2017 Jun; 37(6):2947-2957. PubMed ID: 28551632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
    Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of pRb, p53, p16 and cyclin D1 and their clinical implications in urothelial carcinoma.
    Lee K; Jung ES; Choi YJ; Lee KY; Lee A
    J Korean Med Sci; 2010 Oct; 25(10):1449-55. PubMed ID: 20890425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic alterations in Rb pathway have more prognostic influence than p53 pathway proteins in oral carcinoma.
    Jayasurya R; Sathyan KM; Lakshminarayanan K; Abraham T; Nalinakumari KR; Abraham EK; Nair MK; Kannan S
    Mod Pathol; 2005 Aug; 18(8):1056-66. PubMed ID: 15731778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
    Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
    Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of immunohistochemical staining of cell-cycle regulators: the prediction of recurrence of functioning pituitary adenoma.
    Lee EH; Kim KH; Kwon JH; Kim HD; Kim YZ
    World Neurosurg; 2014; 81(3-4):563-75. PubMed ID: 24067736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal expression of p16(INK4a), cyclin D1, cyclin-dependent kinase 4 and retinoblastoma protein in gastric carcinomas.
    Kishimoto I; Mitomi H; Ohkura Y; Kanazawa H; Fukui N; Watanabe M
    J Surg Oncol; 2008 Jul; 98(1):60-6. PubMed ID: 18484097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
    Tzai TS; Tsai YS; Chow NH
    Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast.
    Geradts J; Ingram CD
    Mod Pathol; 2000 Sep; 13(9):945-53. PubMed ID: 11007034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
    Okami K; Reed AL; Cairns P; Koch WM; Westra WH; Wehage S; Jen J; Sidransky D
    Oncogene; 1999 Jun; 18(23):3541-5. PubMed ID: 10376532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas.
    Azechi H; Nishida N; Fukuda Y; Nishimura T; Minata M; Katsuma H; Kuno M; Ito T; Komeda T; Kita R; Takahashi R; Nakao K
    Oncology; 2001; 60(4):346-54. PubMed ID: 11408803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein.
    Nielsen NH; Emdin SO; Cajander J; Landberg G
    Oncogene; 1997 Jan; 14(3):295-304. PubMed ID: 9018115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer.
    Chatterjee SJ; George B; Goebell PJ; Alavi-Tafreshi M; Shi SR; Fung YK; Jones PA; Cordon-Cardo C; Datar RH; Cote RJ
    J Pathol; 2004 Jul; 203(3):762-70. PubMed ID: 15221935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of cyclin D1 and p16 expression correlates with local recurrence in nasopharyngeal carcinoma following radiotherapy.
    Hwang CF; Cho CL; Huang CC; Wang JS; Shih YL; Su CY; Chang HW
    Ann Oncol; 2002 Aug; 13(8):1246-51. PubMed ID: 12181248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of pRB, p16 and cyclin D1 in colonic carcinogenesis.
    Ayhan S; Isisag A; Saruc M; Nese N; Demir MA; Kucukmetin NT
    Hepatogastroenterology; 2010; 57(98):251-6. PubMed ID: 20583423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant analysis of p16/INK4, cyclin D1, and retinoblastoma protein expression in esophageal squamous cell carcinoma.
    Nakamura T; Ide H; Eguchi R; Hayashi K; Takasaki K
    Hepatogastroenterology; 2003; 50(53):1321-6. PubMed ID: 14571727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas.
    Bilyk OO; Pande NT; Buchynska LG
    Exp Oncol; 2011 Sep; 33(3):150-6. PubMed ID: 21956468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma.
    Jayasurya R; Francis G; Kannan S; Lekshminarayanan K; Nalinakumari KR; Abraham T; Abraham EK; Nair MK
    Int J Cancer; 2004 May; 109(5):710-6. PubMed ID: 14999779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours.
    Gugger M; Kappeler A; Vonlanthen S; Altermatt HJ; Ris HB; Lardinois D; Borner MM; Heighway J; Betticher DC
    Lung Cancer; 2001; 33(2-3):229-39. PubMed ID: 11551418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of p53 and retinoblastoma pathways in canine hemangiosarcoma.
    Yonemaru K; Sakai H; Murakami M; Kodama A; Mori T; Yanai T; Maruo K; Masegi T
    J Vet Med Sci; 2007 Mar; 69(3):271-8. PubMed ID: 17409643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.